Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics
Peptidomimetic motilin antagonists ( 17c and 17d) were identified. Both compounds dose-dependently suppressed motilin-induced colonic and gastric motility in conscious dogs. We successfully discovered peptidomimetic motilin antagonists ( 17c and 17d) through the improvement of physicochemical proper...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2009-07, Vol.19 (13), p.3426-3429 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Peptidomimetic motilin antagonists (
17c and
17d) were identified. Both compounds dose-dependently suppressed motilin-induced colonic and gastric motility in conscious dogs.
We successfully discovered peptidomimetic motilin antagonists (
17c and
17d) through the improvement of physicochemical properties of a tetrapeptide antagonist (
2). Furthermore, with oral administration and based on motilin antagonistic activity, both compounds suppressed motilin-induced colonic and gastric motility in conscious dogs. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2009.05.059 |